The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER
TITANIUM DIOXIDE, OCTINOXATE, and ENSULIZOLE · TITANIUM DIOXIDE 1.77 g/40mL; OCTINOXATE 1.71 g/40mL; ENSULIZOLE .428 g/40mL · Emulsion · Topical · Shiseido Americas Corporation
NDC 58411-0657-10 · 1 TUBE in 1 CARTON / 40 mL in 1 TUBE · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- M020
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of TITANIUM DIOXIDE, OCTINOXATE, and ENSULIZOLE (Emulsion)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Shiseido Americas Corporation | TITANIUM DIOXIDE 1.77 g/40mL; OCTINOXATE 1.71 g/40mL; ENSULIZOLE .428 g/40mL | Aug 26, 2026 | Sep 2, 2026 |
| Shiseido Americas Corporation | TITANIUM DIOXIDE .428 g/40mL; OCTINOXATE 1.71 g/40mL; ENSULIZOLE 1.77 g/40mL | Jul 22, 2026 | Aug 19, 2026 |
| Shiseido Americas Corporation | ENSULIZOLE .428 g/40mL; OCTINOXATE 1.71 g/40mL; TITANIUM DIOXIDE 1.77 g/40mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER — NDC 58411-0657-10," retrieved September 3, 2026, https://drugdashboards.com/drug/58411065710.
Free to cite with attribution — see how the data is put together.